These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24043654)

  • 1. Addressing cost-related barriers to prescription drug use in Canada.
    Tang KL; Ghali WA; Manns BJ
    CMAJ; 2014 Mar; 186(4):276-80. PubMed ID: 24043654
    [No Abstract]   [Full Text] [Related]  

  • 2. Should national pharmacare apply a value-based insurance design?
    Yeung K; Morgan SG
    CMAJ; 2019 Jul; 191(29):E811-E815. PubMed ID: 31332049
    [No Abstract]   [Full Text] [Related]  

  • 3. 4 easy ways to cut your drug spending. Minimizing your prescription drug costs is easier than it may seem.
    Harv Womens Health Watch; 2014 Nov; 22(3):1, 7. PubMed ID: 26058101
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins.
    McRae I; van Gool K; Hall J; Yen L
    Appl Health Econ Health Policy; 2017 Oct; 15(5):625-634. PubMed ID: 28660496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.
    Gaffney A; Lexchin J; ;
    BMJ; 2018 May; 361():k1039. PubMed ID: 29773533
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing the burden of medication costs to improve medication adherence.
    Shaw CR
    Nurse Pract; 2014 Jul; 39(7):43-7. PubMed ID: 24932794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cost on adherence to prescription medications in Canada.
    Law MR; Cheng L; Dhalla IA; Heard D; Morgan SG
    CMAJ; 2012 Feb; 184(3):297-302. PubMed ID: 22249979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available.
    Socal MP; Bai G; Anderson GF
    JAMA Intern Med; 2019 Jun; 179(6):832-833. PubMed ID: 30882842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 11. Surprising ways to cut your drug costs: even with insurance you might be paying too much.
    Consum Rep; 2013 Sep; 78(9):26-30. PubMed ID: 23930299
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription-drug coupons--no such thing as a free lunch.
    Ross JS; Kesselheim AS
    N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-control mechanisms in Canadian private drug plans.
    Kratzer J; McGrail K; Strumpf E; Law MR
    Healthc Policy; 2013 Aug; 9(1):35-43. PubMed ID: 23968672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medication supply of privately insured patients in 2010].
    Wild F
    Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies used by adults to reduce their prescription drug costs.
    Cohen RA; Kirzinger WK; Gindi RM
    NCHS Data Brief; 2013 Apr; (119):1-8. PubMed ID: 23742848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value-Based Pricing and State Reform of Prescription Drug Costs.
    Hwang TJ; Kesselheim AS; Sarpatwari A
    JAMA; 2017 Aug; 318(7):609-610. PubMed ID: 28692713
    [No Abstract]   [Full Text] [Related]  

  • 17. Measures to cut Germany's drugs bill start to take effect.
    Stafford N
    BMJ; 2011 Sep; 343():d5999. PubMed ID: 21930811
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimated cost of universal public coverage of prescription drugs in Canada.
    Morgan SG; Law M; Daw JR; Abraham L; Martin D
    CMAJ; 2015 Apr; 187(7):491-497. PubMed ID: 25780047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?
    Fairman KA; Curtiss FR
    J Manag Care Pharm; 2012 Mar; 18(2):146-55. PubMed ID: 22380473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.